Skip to main content
Premium Trial:

Request an Annual Quote

Vincent Bruno: Transcriptomics and Fungal Pathogenesis

Premium

Recommended by: Claire Fraser-Liggett, University of Maryland

Vincent Bruno became interested in the molecular aspects of fungal pathogenesis during the first year of his graduate studies. As a PhD student, Bruno worked to generate mutants in Candida albicans in a high-throughput manner. "This was an awful lot of fun because we made several really interesting connections that would not have been made — or would have taken way longer — using a step-by-step scientific method," he says.

Now an assistant professor at the University of Maryland School of Medicine's Institute for Genome Sciences, Bruno is using transcriptomics and other approaches to chip away at "the ability of C. albicans to cause disease," he says. "My work has the potential to identify novel drug targets."

Bruno credits his PhD advisor, Carnegie Mellon University's Aaron Mitchell, with teaching him to always "look where the light is not shining," he says. "The potential of having to delve into a brand-new area within a field is what keeps me excited about using genomics and functional genomics to study biological problems."

Publication of note

Among his publications, Bruno considers a 2010 Genome Research paper in which he and his colleagues mapped the C. albicans transcriptome using RNA-seq as particularly influential. "We identified about 600 new genes that were not previously known," Bruno says.

Looking ahead

In the next five to 10 years, Bruno says he expects researchers to have maxed out their efforts to deep-sequence microorganisms. Then, he adds, "there will be a real push to transform all the sequencing data into functional, biologically useful information."

The Scan

Just Breathing

A new analysis suggests that most Mycobacterium tuberculosis is spread by aerosols from breathing, rather than by coughing, the New York Times reports.

Just Like This One

NPR reports that the World Health Organization has hired a South African biotech company to recreate mRNA vaccine for SARS-CoV-2 that is similar to the one developed by Moderna.

Slow Start

The Wall Street Journal reports that Biogen's Alzheimer's disease treatment had revenues for July through September that totaled $300,000.

Genome Research Papers on Cancer Chromatin, Splicing in the Thymus, Circular RNAs in Cancer

In Genome Research this week: analysis of bivalent chromatin sites, RBFOX splicing factors' role in thymic epithelial cells, and more.